Coinbase Soars on 'Everything Exchange' and Regulatory Hopes, but Report Remains Skeptical

What happened

Coinbase shares rallied sharply on July 21, driven by updates on its global 'Everything Exchange' initiative, which aims to unify spot, derivatives, staking, and on-chain settlement, along with broad regulatory tailwinds and bullish market sentiment. However, the latest DeepValue master report maintains a POTENTIAL SELL rating, highlighting that Q1'26 produced a $394M net loss and that derivatives growth is 'due mainly' to the Deribit acquisition, not organic expansion. The report argues that U.S. regulatory approvals for perpetuals remain case-by-case, limiting the pace of onshore scaling, and that the current valuation (62.5x P/E, 26.5x EV/EBITDA) prices in a rebound that lacks concrete evidence. While the 'Everything Exchange' narrative excites investors, the company still needs to prove Q2 opex reductions and GAAP profitability improvement, as well as faster CFTC approvals, to justify the current price. Without these proofs, the rally may prove unsustainable, and downside risk remains significant.

Implication

The July 21 surge is a sentiment-driven move that does not change the underlying earning power or regulatory timeline. Our base case implies ~$185, and without Q2 GAAP loss narrowing below $(100)M and signs of broader CFTC perp approvals, the stock offers ~3% upside from here at best. Given the 30% bear-case downside to $140, risk/reward remains unfavorable. We would use rallies above $220 to trim positions and look to re-enter near $150 if proof points emerge. The thesis delta is minimal: the market is buying a narrative that our filing analysis questions, so we stay cautious pending hard evidence of a structural turnaround.

Thesis delta

The positive news flow around the 'Everything Exchange' and regulatory tailwinds has not altered our thesis. Q1 results still show a fragile earnings base, and derivatives growth is acquisition-dependent. Until Q2 proves otherwise, the POTENTIAL SELL rating and $185 base case remain intact.